Peramivir News
Most Popular Peramivir Story
BioCryst reports positive late-stage flu data for peramivir
With the world's first pandemic in more than four decades covering the globe, BioCryst took another step toward FDA approval for its flu therapy peramivir with the announcement that two late-stage Read more...
Latest Headlines
- January 14, 2011
- November 5, 2009
- October 22, 2009
- September 21, 2009
- September 15, 2009
- November 13, 2007
- September 20, 2007
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
